FDA Grants Modified Risk Tobacco Product Orders for 20 Zyn Products - CStore Decisions
FDA granted modified risk tobacco product (MRTP) orders for 20 Zyn nicotine pouch products, allowing them to be marketed with reduced risk claims. This is a significant regulatory change that may affect competitors and retailers.
Aforeworn detected this change in the Vape & Tobacco Retail Compliance space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Vape shops, tobacco retailers, e-liquid manufacturers, distributors/wholesalers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately, as unauthorized claims could trigger FDA enforcement.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Vape & Tobacco Retail Compliance continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA authorized 20 Zyn products to be marketed as modified risk, meaning they can claim reduced harm compared to cigarettes. This sets a precedent for nicotine pouch products and may influence enforcement priorities.
Who it affects
Vape shops, tobacco retailers, e-liquid manufacturers, distributors/wholesalers
What you must do
Review your product inventory to ensure compliance with marketing claims. Do not make similar reduced-risk claims for your products unless you have FDA authorization.
Deadline
Immediately, as unauthorized claims could trigger FDA enforcement.
Never miss a change like this again
Aforeworn watches Vape & Tobacco Retail Compliance around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Vape & Tobacco Retail Compliance
- US FDA proposes rule to tighten oversight of foreign tobacco makers - KELO-AM
- Heated tobacco: FDA renews IQOS exposure-modification authorization - Vera Health
- FDA Authorizes Modified Risk Claims for ZYN Nicotine Pouches: A Landmark Step for Tobacco Harm Reduction - The National Law Review
- FDA Finally Issues Proposed Rule to Require Foreign Tobacco Manufacturers to Register Facilities and List Products - Tobacco Reporter
- FDA Proposal Would Allow Oversight of Foreign Manufacturers - Tobacco Reporter